Gut microbiota-derived propionate reduces cancer cell proliferation in the liver

British Journal of Cancer

Volumn 107, Issue 8, 2012, Pages 1337-1344

  Bindels, L B ^a   Porporato, P ^a   Dewulf, E M ^a   Verrax, J ^a   Neyrinck, A M ^a   Martin, J C ^b   Scott, K P ^b   Buc Calderon, P ^a   Feron, O ^a   Muccioli, G G ^a   Sonveaux, P ^a   Cani, P D ^a   Delzenne, N M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Cancer cells; FFA2 FFAR2 GPR43; Gut microbiota; Inulin type fructans; Propionate

Indexed keywords

BCR ABL PROTEIN; CYCLIC AMP; DNA 16S; DRINKING WATER; FREE FATTY ACID RECEPTOR 2; FRUCTAN; INULIN TYPE FRUCTAN; PROPIONIC ACID; RECEPTOR; SHORT CHAIN FATTY ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL GROWTH; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DIETARY INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLORA; LIVER; MASS SPECTROMETRY; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEPTOR BINDING; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALS; CELL PROLIFERATION; DIET; DISEASE MODELS, ANIMAL; FATTY ACIDS, VOLATILE; FEMALE; FRUCTANS; INTESTINES; LEUKEMIA; LIVER; METAGENOME; MICE; MICE, INBRED BALB C; PREBIOTICS; PROPIONATES; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84867404198     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.409     Document Type: Article

References (34)

1. Alric R, Cociglio M, Blayac JP, Puech R (1981) Performance evaluation of a reversed-phase, high-performance liquid chromatographic assay of valproic acid involving a "solvent demixing" extraction procedure and precolumn derivatisation. J Chromatogr 224: 289-299 (Pubitemid 11054824)
2. Aoyama M, Kotani J, Usami M (2010) Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways. Nutrition 26(6): 653-661
3. Bindels LB, Beck R, Schakman O, Martin JC, De Backer FC, Sohet FM, Dewulf EM, Pachikian BD, Neyrinck AM, Thissen JP, Verrax J, Calderon PB, Pot B, Grangette C, Cani PD, Delzenne NM (2012) Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model. PLoS One 7(6): e37971
4. Bray J, Sludden J, Griffin MJ, Cole M, Verrill M, Jamieson D, Boddy AV (2010) Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide. Br J Cancer 102(6): 1003-1009
5. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, Pike NB, Strum JC, Steplewski KM, Murdock PR, Holder JC, Marshall FH, Szekeres PG, Wilson S, Ignar DM, Foord SM, Wise A, Dowell SJ (2003) The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278(13): 11312-11319 (Pubitemid 36792688)
6. Busserolles J, Gueux E, Rock E, Demigne C, Mazur A, Rayssiguier Y (2003) Oligofructose protects against the hypertriglyceridemic and pro-oxidative effects of a high fructose diet in rats. J Nutr 133(6): 1903-1908 (Pubitemid 36666533)
7. Cani PD, Knauf C, Iglesias MA, Drucker DJ, Delzenne NM, Burcelin R (2006) Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like Peptide 1 receptor. Diabetes 55(5): 1484-1490 (Pubitemid 44195391)
8. Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR, Delzenne NM (2007) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50(11): 2374-2383 (Pubitemid 47512397)
9. Cherbut C, Michel C, Lecannu G (2003) The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats. J Nutr 133(1): 21-27 (Pubitemid 36070571)
10. Cox MA, Jackson J, Stanton M, Rojas-Triana A, Bober L, Laverty M, Yang X, Zhu F, Liu J, Wang S, Monsma F, Vassileva G, Maguire M, Gustafson E, Bayne M, Chou CC, Lundell D, Jenh CH (2009) Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines. World J Gastroenterol 15(44): 5549-5557
11. Daubioul C, Rousseau N, Demeure R, Gallez B, Taper H, Declerck B, Delzenne N (2002) Dietary fructans, but not cellulose, decrease triglyceride accumulation in the liver of obese Zucker fa/fa rats. J Nutr 132(5): 967-973 (Pubitemid 34493561)
12. Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GM, Neyrinck AM, Possemiers S, Van HA, Francois P, de Vos WM, Delzenne NM, Schrenzel J, Cani PD (2011) Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptinresistant mice. Diabetes 60(11): 2775-2786
13. Fiskus W, Pranpat M, Bali P, Balasis M, Kumaraswamy S, Boyapalle S, Rocha K, Wu J, Giles F, Manley PW, Atadja P, Bhalla K (2006) Combined effects of novel tyrosine kinase inhibitor AMN107 and histone deacetylase inhibitor LBH589 against Bcr-Abl-expressing human leukemia cells. Blood 108(2): 645-652 (Pubitemid 44061366)
14. Guarner F, Malagelada JR (2003) Gut flora in health and disease. Lancet 361(9356): 512-519 (Pubitemid 36173720)
15. Hinnebusch BF, Meng S, Wu JT, Archer SY, Hodin RA (2002) The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 132(5): 1012-1017 (Pubitemid 34493567)
16. Hong YH, Nishimura Y, Hishikawa D, Tsuzuki H, Miyahara H, Gotoh C, Choi KC, Feng DD, Chen C, Lee HG, Katoh K, Roh SG, Sasaki S (2005) Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology 146(12): 5092-5099 (Pubitemid 41653022)
17. Kondegowda NG, Meaney MP, Baker C, Ju YH (2011) Effects of nondigestible carbohydrates on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Nutr Cancer 63(1): 55-64
18. Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, Brezillon S, Dupriez V, Vassart G, Van DJ, Parmentier M, Detheux M (2003) Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278(28): 25481-25489 (Pubitemid 36835299)
19. Lee T, Schwandner R, Swaminath G, Weiszmann J, Cardozo M, Greenberg J, Jaeckel P, Ge H, Wang Y, Jiao X, Liu J, Kayser F, Tian H, Li Y (2008) Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2. Mol Pharmacol 74(6): 1599-1609
20. Louis P, Scott KP, Duncan SH, Flint HJ (2007) Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol 102(5): 1197-1208 (Pubitemid 46633434)
21. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR (2009) Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461(7268): 1282-1286
22. Montillo M, Hamblin T, Hallek M, Montserrat E, Morra E (2005) Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies. Haematologica 90(3): 391-399 (Pubitemid 40388989)
23. Neish AS (2009) Microbes in gastrointestinal health and disease. Gastroenterology 136(1): 65-80
24. Pool-Zobel BL, Sauer J (2007) Overview of experimental data on reduction of colorectal cancer risk by inulin-type fructans. J Nutr 137(11 Suppl): 2580S-2584S (Pubitemid 350058740)
25. Ren R (2005) Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer 5(3): 172-183 (Pubitemid 40314949)
26. Siavoshian S, Segain JP, Kornprobst M, Bonnet C, Cherbut C, Galmiche JP, Blottiere HM (2000) Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut 46(4): 507-514 (Pubitemid 30305815)
27. Sonveaux P, Vegran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, De Saedeleer CJ, Kennedy KM, Diepart C, Jordan BF, Kelley MJ, Gallez B, Wahl ML, Feron O, Dewhirst MW (2008) Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 118(12): 3930-3942
28. Sundstrom C, Nilsson K (1976) Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 17(5): 565-577
29. Tang Y, Chen Y, Jiang H, Nie D (2011a) Short-chain fatty acids induced autophagy serves as an adaptive strategy for retarding mitochondriamediated apoptotic cell death. Cell Death Differ 18(4): 602-618
30. Tang Y, Chen Y, Jiang H, Robbins GT, Nie D (2011b) G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer. Int J Cancer 128(4): 847-856
31. Taper HS, Delzenne NM, Roberfroid MB (1997) Growth inhibition of transplantable mouse tumors by non-digestible carbohydrates. Int J Cancer 71(6): 1109-1112 (Pubitemid 27252897)
32. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, Cameron J, Grosse J, Reimann F, Gribble FM (2012) Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-proteincoupled receptor FFAR2. Diabetes 61(2): 364-371
33. Vinolo MA, Ferguson GJ, Kulkarni S, Damoulakis G, Anderson K, Bohlooly Y, Stephens L, Hawkins PT, Curi R (2011) SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PLoS One 6(6): e21205
34. Wang Y, Jiao X, Kayser F, Liu J, Wang Z, Wanska M, Greenberg J, Weiszmann J, Ge H, Tian H, Wong S, Schwandner R, Lee T, Li Y (2010) The first synthetic agonists of FFA2: discovery and SAR of phenylacetamides as allosteric modulators. Bioorg Med Chem Lett 20(2): 493-498